Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer

被引：0
|
作者：
Leonardo Roberto da Silva
Camila Annicchino de Andrade
Fabrício Brenelli
Susana Ramalho
Tomás Reinert
Alessandra Borba Anton de Souza
Ana Elisa Ribeiro da Silva
Maria Beatriz de Paula Leite Kraft
Vivian Castro Antunes de Vasconcelos
Antônio Luiz Frasson
Renato Zochio Torresan
Cesar Cabello
Matthew J. Ellis
Luiz Carlos Zeferino
机构：
[1] State University of Campinas (UNICAMP),Faculty of Medical Sciences, Department of Obstetrics and Gynecology
[2] Centro de Pesquisa da Serra Gaúcha (CEPESG),Breast Cancer Center, Hospital São Lucas
[3] Latin American Cooperative Oncology Group (LACOG),Lester and Sue Smith Breast Cancer Center
[4] Pontifical Catholic University of Rio Grande Do Sul (PUCRS),undefined
[5] Baylor College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 186卷
关键词：
Neoadjuvant therapies; Breast neoplasms; Sentinel lymph node biopsy; Aromatase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：753 / 760
页数：7
相关论文
共 50 条
  • [1] Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer
    da Silva, Leonardo Roberto
    de Andrade, Camila Annicchino
    Brenelli, Fabricio
    Ramalho, Susana
    Reinert, Tomas
    de Souza, Alessandra Borba Anton
    da Silva, Ana Elisa Ribeiro
    de Paula Leite Kraft, Maria Beatriz
    de Vasconcelos, Vivian Castro Antunes
    Frasson, Antonio Luiz
    Torresan, Renato Zochio
    Cabello, Cesar
    Ellis, Matthew J.
    Zeferino, Luiz Carlos
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (03) : 753 - 760
  • [2] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [3] Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer
    Matikas, Alexios
    Foukakis, Theodoros
    Michalakis, Ilias
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 319 - 326
  • [4] Endocrine therapy for ER-positive/HER2-negative metastatic breast cancer
    Reinert, Tomas
    de Paula, Bruno
    Shafaee, Maryam Nemati
    Souza, Pedro Henrique
    Ellis, Matthew J.
    Bines, Jose
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (03)
  • [5] Novel Endocrine Therapy Agents in ER-Positive, HER2-Negative Breast Cancer
    Hamilton, Erika P.
    Rugo, Hope S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (03) : 125 - 127
  • [6] New Approaches to Endocrine Therapy in ER-Positive, HER2-Negative Breast Cancer
    Hamilton, Erika P.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (06) : 356 - 358
  • [7] Real world outcomes of neoadjuvant chemotherapy in ER-positive/PR-positive, HER2-negative breast cancer
    Kurian, Matthew
    Trybula, Marcus
    Patell, Kanchi
    Guzik, Gregory
    Margevicius, Seunghee
    Fu, Pingfu
    Montero, Alberto
    Martin, James
    CANCER RESEARCH, 2024, 84 (09)
  • [8] Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
    Ho Hyun Ryu
    Sei Hyun Ahn
    Seon Ok Kim
    Jeong Eun Kim
    Ji sun Kim
    Jin-Hee Ahn
    Kyung Hae Jung
    Sung-Bae Kim
    Beom Seok Ko
    Jong Won Lee
    Byung Ho Son
    Hee Jung Shin
    Hak Hee Kim
    Gyung yub Gong
    Hee Jeong Kim
    Scientific Reports, 11
  • [9] Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer
    Ryu, Ho Hyun
    Ahn, Sei Hyun
    Kim, Seon Ok
    Kim, Jeong Eun
    Kim, Ji Sun
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Kim, Sung-Bae
    Ko, Beom Seok
    Lee, Jong Won
    Son, Byung Ho
    Shin, Hee Jung
    Kim, Hak Hee
    Gong, Gyung Yub
    Kim, Hee Jeong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Axillary Response to Neoadjuvant Therapy in Node-Positive ER-Positive, HER2-Negative Breast Cancer
    Friedman-Eldar, Orli
    Ozmen, Tolga
    Reyes, Fernando Valle
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susane B.
    Moller, Mecker
    Franceschi, Dido
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S236 - S236
12345